The CD40 costimulatory pathway was found to be upregulated in the blood of 56% ALS patients, and the inhibition of CD40 L was found to delay paralysis and prolong survival in an ALS mouse model (Lincecum et al., 2010). Here, CD40LG is linked to amyotrophic lateral sclerosis.